Neptunus
-
GSK and Shenzhen Neptunus to Develop Vaccines in China
GlaxoSmithKline (GSK) has entered into an agreement to form a Joint Venture (JV) with Shenzhen Neptunus Interlong Bio-Technique (Shenzhen Neptunus), focused on developing and manufacturing influenza vaccines for the Chinese market. The alliance wi…
Neptunus | 19 June 2009
